# EDGAR Filing Document

**Accession Number:** 0000352665
**File Stem:** 0001752724-25-182337
**Filing Date:** 2025-7
**Character Count:** 20218
**Document Hash:** 426c9d1b89f391d982d097bb4b44e901
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001752724-25-182337.hdr.sgml**: 20250729

**ACCESSION NUMBER**: 0001752724-25-182337

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250530

**FILED AS OF DATE**: 20250729

**DATE AS OF CHANGE**: 20250729

**PERIOD START**: 20251130

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** PRUDENTIAL SECTOR FUNDS, INC.
- **CENTRAL INDEX KEY:** 0000352665

**ORGANIZATION NAME:**
- **EIN:** 133071974
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 1130

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-03175
- **FILM NUMBER:** 251160652

**BUSINESS ADDRESS:**
- **STREET 1:** 655 BROAD STREET
- **STREET 2:** 6TH FLOOR
- **CITY:** NEWARK
- **STATE:** NJ
- **ZIP:** 07102
- **BUSINESS PHONE:** (973) 802-5032

**MAIL ADDRESS:**
- **STREET 1:** 655 BROAD STREET
- **STREET 2:** 6TH FLOOR
- **CITY:** NEWARK
- **STATE:** NJ
- **ZIP:** 07102

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PRUDENTIAL SECTOR FUNDS INC d/b/a JENNISONDRYDEN SECTOR FUNDS
- **DATE OF NAME CHANGE:** 20090113

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PRUDENTIAL SECTOR FUNDS INC
- **DATE OF NAME CHANGE:** 20080902

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** JENNISON SECTOR FUNDS INC
- **DATE OF NAME CHANGE:** 20030716

## Series and Classes Contracts Data

### PGIM Jennison Health Sciences Fund (Series ID: S000004380)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000012121 | Class A      | PHLAX           |
| C000012123 | Class C      | PHLCX           |
| C000012124 | Class Z      | PHSZX           |
| C000110073 | Class R      | PJHRX           |
| C000165347 | Class R6     | PHLQX           |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** Prudential Sector Funds, Inc.

- **b. Investment Company Act file number:** 811-03175

- **c. CIK number of Registrant:** 0000352665

- **d. LEI of Registrant:** 549300IPCXL88G4QUI19

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 655 Broad Street

  - **City:** Newark

  - **State:** NJ

  - **Foreign country:** US

  - **Zip / Postal Code:** 07102-4077

  - **Telephone number:** 1-800-225-1852

**Item A.2. Information about the Series.**

- **a. Name of Series:** PGIM Jennison Health Sciences Fund

- **b. EDGAR series identifier (if any):** S000004380

- **c. LEI of Series:** S41LI155RNUZ4KJ9CN75

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2025-11-30

- **b. Date as of which information is reported:** 2025-05-30

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $1431764404.22

**Total Liabilities:** $90323010.96

**Net Assets:** $1341441393.26

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000012121 | -5.58%               | -0.58%               | -5.55%               |
| Class ID C000012123 | -5.68%               | -0.58%               | -5.64%               |
| Class ID C000012124 | -5.56%               | -0.54%               | -5.54%               |
| Class ID C000110073 | -5.59%               | -0.63%               | -5.60%               |
| Class ID C000165347 | -5.53%               | -0.56%               | -5.53%               |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $13670834.10             | $-102731194.35                             |
| Month 2  | $10896529.54             | $-22367120.91                              |
| Month 3  | $-5551684.27             | $-75173374.99                              |

### Schedule of Portfolio Investments

| Name                                             | Title                                            | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Newamsterdam Pharma Co NV                        | Newamsterdam Pharma Co NV                        | CUSIP: 000000000<br>LEI: 984500B6549TF6E14D36 | Long             | EC               | CORP              | NL        |    777280 | NS      | $14076540.80  | 1.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Vertex Pharmaceuticals Inc                       | Vertex Pharmaceuticals Inc                       | CUSIP: 92532F100<br>LEI: 54930015RAQRRZ5ZGJ91 | Long             | EC               | CORP              | US        |    150218 | NS      | $66403866.90  | 4.95%             |  |  |  | No            |                  1 | On Loan: No      |
| (PIPA070) PGIM Core Government Money Market Fund | (PIPA070) PGIM Core Government Money Market Fund | CUSIP: 000000000<br>LEI: N/A                  | Long             | STIV             | RF                | US        | 146872056 | NS      | $146872055.52 | 10.95%            |  |  |  | No            |                  1 | On Loan: No      |
| Intuitive Surgical Inc                           | Intuitive Surgical Inc                           | CUSIP: 46120E602<br>LEI: 54930052SRG011710797 | Long             | EC               | CORP              | US        |     15086 | NS      | $8332601.24   | 0.62%             |  |  |  | No            |                  1 | On Loan: No      |
| Sionna Therapeutics Inc                          | Sionna Therapeutics Inc                          | CUSIP: 829401108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    553942 | NS      | $7583465.98   | 0.57%             |  |  |  | No            |                  1 | On Loan: —       |
| Straumann Holding AG                             | Straumann Holding AG                             | CUSIP: 000000000<br>LEI: 50670046ML5FVIM60Z37 | Long             | EC               | CORP              | CH        |    114927 | NS      | $14782856.83  | 1.10%             |  |  |  | No            |                  2 | On Loan: No      |
| Vaxcyte Inc                                      | Vaxcyte Inc                                      | CUSIP: 92243G108<br>LEI: 254900M7NMHTGASX8D95 | Long             | EC               | CORP              | US        |    388884 | NS      | $12634841.16  | 0.94%             |  |  |  | No            |                  1 | On Loan: No      |
| Cabaletta Bio Inc                                | Cabaletta Bio Inc                                | CUSIP: 12674W109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   1378804 | NS      | $2578363.48   | 0.19%             |  |  |  | No            |                  1 | On Loan: —       |
| Revvity Inc                                      | Revvity Inc                                      | CUSIP: 714046109<br>LEI: 549300IKL1SDPFI7N655 | Long             | EC               | CORP              | US        |    219203 | NS      | $19820335.26  | 1.48%             |  |  |  | No            |                  1 | On Loan: —       |
| Tandem Diabetes Care Inc                         | Tandem Diabetes Care Inc                         | CUSIP: 875372203<br>LEI: 549300JEPFOD0K4D3I05 | Long             | EC               | CORP              | US        |    732318 | NS      | $14514542.76  | 1.08%             |  |  |  | No            |                  1 | On Loan: No      |
| AstraZeneca PLC                                  | AstraZeneca PLC                                  | CUSIP: 046353108<br>LEI: PY6ZZQWO2IZFZC3IOL08 | Long             | EC               | CORP              | GB        |    854038 | NS      | $62199587.54  | 4.64%             |  |  |  | No            |                  1 | On Loan: No      |
| Crinetics Pharmaceuticals Inc                    | Crinetics Pharmaceuticals Inc                    | CUSIP: 22663K107<br>LEI: 549300Q1CNFXK5P31D28 | Long             | EC               | CORP              | US        |    675458 | NS      | $20608223.58  | 1.54%             |  |  |  | No            |                  1 | On Loan: No      |
| Neurocrine Biosciences Inc                       | Neurocrine Biosciences Inc                       | CUSIP: 64125C109<br>LEI: 549300FECER0XBN49756 | Long             | EC               | CORP              | US        |    520854 | NS      | $64075459.08  | 4.78%             |  |  |  | No            |                  1 | On Loan: No      |
| Argenx SE                                        | Argenx SE                                        | CUSIP: 04016X101<br>LEI: 7245009C5FZE6G9ODQ71 | Long             | EC               | CORP              | NL        |    113310 | NS      | $64956090.60  | 4.84%             |  |  |  | No            |                  1 | On Loan: No      |
| GE HealthCare Technologies Inc                   | GE HealthCare Technologies Inc                   | CUSIP: 36266G107<br>LEI: 549300OI9J7XOWZMUN85 | Long             | EC               | CORP              | US        |    358242 | NS      | $25270390.68  | 1.88%             |  |  |  | No            |                  1 | On Loan: No      |
| Blueprint Medicines Corp                         | Blueprint Medicines Corp                         | CUSIP: 09627Y109<br>LEI: 5299004CC60O9T5HVM83 | Long             | EC               | CORP              | US        |    183012 | NS      | $18548266.20  | 1.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Beta Bionics Inc                                 | Beta Bionics Inc                                 | CUSIP: 08659B102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     43415 | NS      | $748474.60    | 0.06%             |  |  |  | No            |                  1 | On Loan: —       |
| Apogee Therapeutics Inc                          | Apogee Therapeutics Inc                          | CUSIP: 03770N101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    112496 | NS      | $4121853.44   | 0.31%             |  |  |  | No            |                  1 | On Loan: —       |
| Thermo Fisher Scientific Inc                     | Thermo Fisher Scientific Inc                     | CUSIP: 883556102<br>LEI: HCHV7422L5HDJZCRFL38 | Long             | EC               | CORP              | US        |    118988 | NS      | $47930746.16  | 3.57%             |  |  |  | No            |                  1 | On Loan: No      |
| Alnylam Pharmaceuticals Inc                      | Alnylam Pharmaceuticals Inc                      | CUSIP: 02043Q107<br>LEI: 529900S3ZI14OWRJII50 | Long             | EC               | CORP              | US        |    138476 | NS      | $42174250.56  | 3.14%             |  |  |  | No            |                  1 | On Loan: No      |
| Mineralys Therapeutics Inc                       | Mineralys Therapeutics Inc                       | CUSIP: 603170101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    738891 | NS      | $11511921.78  | 0.86%             |  |  |  | No            |                  1 | On Loan: —       |
| UCB SA                                           | UCB SA                                           | CUSIP: 000000000<br>LEI: 2138008J191VLSGY5A09 | Long             | EC               | CORP              | BE        |    197591 | NS      | $35945670.68  | 2.68%             |  |  |  | No            |                  2 | On Loan: No      |
| Verona Pharma PLC                                | Verona Pharma PLC                                | CUSIP: 925050106<br>LEI: 213800EVI6O6J3TIAL06 | Long             | EC               | CORP              | GB        |    464168 | NS      | $37690441.60  | 2.81%             |  |  |  | No            |                  1 | On Loan: No      |
| Novo Nordisk A/S                                 | Novo Nordisk A/S                                 | CUSIP: 670100205<br>LEI: 549300DAQ1CVT6CXN342 | Long             | EC               | CORP              | DK        |    655469 | NS      | $46866033.50  | 3.49%             |  |  |  | No            |                  1 | On Loan: —       |
| Kestra Medical Technologies Lt                   | Kestra Medical Technologies Ltd                  | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     48217 | NS      | $1085846.84   | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Stevanato Group SpA                              | Stevanato Group SpA                              | CUSIP: 000000000<br>LEI: 81560033F7E1CD477507 | Long             | EC               | CORP              | IT        |    523209 | NS      | $11620471.89  | 0.87%             |  |  |  | No            |                  1 | On Loan: —       |
| Metsera Inc                                      | Metsera Inc                                      | CUSIP: 59267L107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    221101 | NS      | $5907818.72   | 0.44%             |  |  |  | No            |                  1 | On Loan: —       |
| Dexcom Inc                                       | Dexcom Inc                                       | CUSIP: 252131107<br>LEI: 549300YSK3QDSFR5EU59 | Long             | EC               | CORP              | US        |    249266 | NS      | $21387022.80  | 1.59%             |  |  |  | No            |                  1 | On Loan: No      |
| Agilent Technologies Inc                         | Agilent Technologies Inc                         | CUSIP: 00846U101<br>LEI: QUIX8Y7A2WP0XRMW7G29 | Long             | EC               | CORP              | US        |     36977 | NS      | $4138465.84   | 0.31%             |  |  |  | No            |                  1 | On Loan: No      |
| PGIM Institutional Money Market Fund - D         | PGIM Institutional Money Market Fund - D         | CUSIP: 000000000<br>LEI: N/A                  | Long             | STIV             | RF                | US        |  85820072 | NS      | $85759998.40  | 6.39%             |  |  |  | No            |                  1 | On Loan: No      |
| Travere Therapeutics Inc                         | Travere Therapeutics Inc                         | CUSIP: 89422G107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    393263 | NS      | $5906810.26   | 0.44%             |  |  |  | No            |                  1 | On Loan: No      |
| Vera Therapeutics Inc                            | Vera Therapeutics Inc                            | CUSIP: 92337R101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    247916 | NS      | $4698008.20   | 0.35%             |  |  |  | No            |                  1 | On Loan: No      |
| Arcutis Biotherapeutics Inc                      | Arcutis Biotherapeutics Inc                      | CUSIP: 03969K108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   2269514 | NS      | $29594462.56  | 2.21%             |  |  |  | No            |                  1 | On Loan: —       |
| Insmed Inc                                       | Insmed Inc                                       | CUSIP: 457669307<br>LEI: 529900Q55QAG41CCAC11 | Long             | EC               | CORP              | US        |    401806 | NS      | $28017932.38  | 2.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Edwards Lifesciences Corp                        | Edwards Lifesciences Corp                        | CUSIP: 28176E108<br>LEI: YA13X31F3V31L8TMPR58 | Long             | EC               | CORP              | US        |    487173 | NS      | $38106672.06  | 2.84%             |  |  |  | No            |                  1 | On Loan: No      |
| Apellis Pharmaceuticals Inc                      | Apellis Pharmaceuticals Inc                      | CUSIP: 03753U106<br>LEI: 254900HS0ZFRXXSB9D42 | Long             | EC               | CORP              | US        |    686301 | NS      | $11619075.93  | 0.87%             |  |  |  | No            |                  1 | On Loan: No      |
| Tarsus Pharmaceuticals Inc                       | Tarsus Pharmaceuticals Inc                       | CUSIP: 87650L103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    382765 | NS      | $16439756.75  | 1.23%             |  |  |  | No            |                  1 | On Loan: —       |
| Lonza Group AG                                   | Lonza Group AG                                   | CUSIP: 000000000<br>LEI: 549300EFW4H2TCZ71055 | Long             | EC               | CORP              | CH        |     49206 | NS      | $34144310.42  | 2.55%             |  |  |  | No            |                  2 | On Loan: No      |
| Kymera Therapeutics Inc                          | Kymera Therapeutics Inc                          | CUSIP: 501575104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    274195 | NS      | $8127139.80   | 0.61%             |  |  |  | No            |                  1 | On Loan: No      |
| CVS Health Corp                                  | CVS Health Corp                                  | CUSIP: 126650100<br>LEI: 549300EJG376EN5NQE29 | Long             | EC               | CORP              | US        |    428269 | NS      | $27426346.76  | 2.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Abbott Laboratories                              | Abbott Laboratories                              | CUSIP: 002824100<br>LEI: HQD377W2YR662HK5JX27 | Long             | EC               | CORP              | US        |    234734 | NS      | $31355767.72  | 2.34%             |  |  |  | No            |                  1 | On Loan: No      |
| Xenon Pharmaceuticals Inc                        | Xenon Pharmaceuticals Inc                        | CUSIP: 98420N105<br>LEI: 549300XV44Q9Z1MIPQ03 | Long             | EC               | CORP              | CA        |    407083 | NS      | $11744344.55  | 0.88%             |  |  |  | No            |                  1 | On Loan: No      |
| Danaher Corp                                     | Danaher Corp                                     | CUSIP: 235851102<br>LEI: S4BKK9OTCEWQ3YHPFM11 | Long             | EC               | CORP              | US        |    140737 | NS      | $26725956.30  | 1.99%             |  |  |  | No            |                  1 | On Loan: No      |
| UnitedHealth Group Inc                           | UnitedHealth Group Inc                           | CUSIP: 91324P102<br>LEI: 549300GHBMY8T5GXDE41 | Long             | EC               | CORP              | US        |    126565 | NS      | $38211239.15  | 2.85%             |  |  |  | No            |                  1 | On Loan: No      |
| Eli Lilly & Co                                   | Eli Lilly & Co                                   | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |    265302 | NS      | $195705326.34 | 14.59%            |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2025-07-29

**Name of Applicant:** Prudential Sector Funds, Inc.

**Signature:** Christian J. Kelly

**Name of Signer:** Christian J. Kelly

**Title:** Chief Financial Officer